UAE – Pharmaceutical giant GSK plc, formerly GlaxoSmithKline plc., with support from Dubai-based pulmonologists and global experts has unveiled its advanced training programme on the management of respiratory diseases dubbed…
Read MoreTag: GSK
China’s WuXi Biologics signs US$1.46B licensing deal with GSK
CHINA – WuXi Biologics, a leading global open-access biologics technology platform, has signed an exclusive global licensing agreement worth up to US$1.46 billion with pharmaceutical giant GSK plc, formerly GlaxoSmithKline…
Read MoreGSK and Aster DM Healthcare expand partnership to support healthy ageing
UAE – GlaxoSmithKline (GSK) and Aster DM Healthcare, a private healthcare service provider, have announced an expansion of their strategic medical partnership to promote healthy ageing in the United Arab…
Read MoreA trio of pharma giants partner with scientists in Singapore for biologics manufacturing
SINGAPORE — GSK, Sanofi, and Takeda are set to collaborate with researchers from the Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS), Nanyang Technological University, Singapore…
Read MoreSCI, GSK donate equipment to Lagos State to assist in public health facilities
NIGERIA – Save the Children International Nigeria (SCI), through the INSPIRING Project, has donated the District Health Information Software 2 (DHIS2) Dashboard App, and 30 internet tablets to the Lagos…
Read MoreGSK to withdraw blood cancer drug from US market after failed trial
USA — British pharma giant GSK is set to withdraw its blood cancer drug Blenrep from the U.S. market, following a request from the Food and Drug Administration. Blenrep belongs…
Read MoreGSK pharma business achieves record profit against the backdrop of consumer health spinoff
UNITED KINGDOM — British drugmaker GlaxoSmithKline that third-quarter net profit rocketed almost ten-fold to 10.3 billion pounds (US$11.5 billion) against the backdrop of the blockbuster spinoff of consumer healthcare unit…
Read MoreChina bans GSK from drug procurement activities for 18 months
CHINA — China has banned the import and sale of GSK’s Avodart (dutasteride) soft capsules through its national bulk-buy drug procurement program effective immediately and will last until April 2024.…
Read MoreGSK shelves hope of rheumatoid arthritis blockbuster after lackluster trial data
UNITED KINGDOM — GSK has announced that it would not pursue regulatory approval for its experimental treatment for moderate-to-severe Rheumatoid Arthritis (RA) after the drug failed to meet a key…
Read MoreJapanese regulator accepts GSK regulatory submission for RSV vaccine candidate in older adults
JAPAN — The Japanese Ministry of Health, Labor, and Welfare (MHLW) has agreed to review GSK’s new drug application (NDA) for its respiratory syncytial virus (RSV) vaccine candidate for use…
Read More